The NEAT1/miR-124-3p/CCL2 axis in chronic kidney disease progression: integrated bioinformatics analysis and experimental validation

Guanting Chen, Linqi Zhang, Yaoxian Wang, Jianfeng Wang, Kang Yang, Xixi Wang, Xu ChenEpigenomics 2025 · DOI

Abstract

EGF,VCAN, CXCL1, MMP7, and particularly CCL2 are potential CKDbiomarkers/therapeutic targets. The NEAT1/miR-124-3p/CCL2 axis is a keyregulatory pathway in CKD. Key limitations include the moderate sample sizes inbioinformatics and clinical cohorts.
BibTeX
@inproceedings{chen2025neat,
  author = {Guanting Chen and Linqi Zhang and Yaoxian Wang and Jianfeng Wang and Kang Yang and Xixi Wang and Xu Chen},
  title = {{The NEAT1/miR-124-3p/CCL2 axis in chronic kidney disease progression: integrated bioinformatics analysis and experimental validation}},
  booktitle = {Epigenomics},
  year = {2025},
  doi = {10.1080/17501911.2025.2548762},
}

Loading related content...

Figure